Abiopharma

To develop and deliver novel therapies to patients, Genmab has formed 20 strategic partnerships with biotechnology and pharmaceutical companies. 01% of the share capital and voting rights in Genmab AS, so that through shares and financial instruments they held the voting rights to a total of 3,304,801 shares in Genmab AS, which amounts to 5. About Genmab Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer.